IPH-AGAA after notexin-induced quadriceps injury in rats
Ideal Pharma Peptide · 2019 · Ideal Pharma Peptide experimental study report
Published 2019-11-26. Indexed 2026-11-13.
Related evidence maps: Military & occupational research ↗
Reported findings and study design
At day 14, the company reported 89.4 ± 1.4% structured or striated muscle-fiber area with IPH-AGAA versus 36.8 ± 1.2% in injured controls.
The investigators assayed TNF-α, IL-1β and IL-10 in blood on day 13 and assessed hematoxylin-and-eosin muscle sections on day 14. The comparator’s formulation is unclear.
Dose, route and schedule
The methods describe oral delivery by pipette in 1 mL daily for 14 days and print 0.58 µg per rat body weight per day without a weight unit. The results instead describe injection. The report does not establish a reproducible dose or route.
Protocol source ↗ · Manufacturer report, methods and histology results text
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Quadriceps histology · day 14 | 89.4 ± 1.4% vs 36.8 ± 1.2% | Area described as structured or striated in treated versus injured control muscle, about 2.4-fold by the report. |
The finding describes tissue appearance after experimental muscle injury. Its relevance to strength or muscle recovery in people is unknown.
Source for these results ↗ · Reviewed 2026-11-13
For research and education. Consult a qualified clinician for medical advice.
Study limitations and source details
Study limitations
- The dose denominator, route and control preparation are unclear. The report does not describe blinded histology assessment.
- The endpoint was microscopic structure. The report provides no functional recovery test or human outcome. Numerical cytokine results are confined to an image table and were not verified.
Available format: Manufacturer report, methods and histology results text
Material reviewed: Reported methods, results and evidence limitations
Source access
Manufacturer report, methods and histology results text
Source reviewed 2026-11-13.
Source type: Manufacturer report
Citation and original source
Original source: Ideal Pharma Peptide. IPH-AGAA after notexin-induced quadriceps injury in rats Ideal Pharma Peptide experimental study report 2019.
Molekul research summary: https://molekul.io/research/iph-agaa-notexin-muscle-2019. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry